CVS to Pay $37.5 Million to Settle Pill Switching Case
Read More:
CVS,
Medicaid,
CVS Pharmacies,
Whistleblowers,
CVS Lawsuit,
Zantac,
Ranitidine,
Business News
CVS is paying $36.7 million to settle allegations that the company defrauded the government by improperly switching patients taking generic Zantac to ...
Wall Street Journal | Jacob Goldstein | Posted 03.28.2008 | Business